Dyadic to participate in bio-manufacturing innovation summit and niimbl national meeting

Jupiter, fla., july 05, 2022 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on further improving, applying and deploying its proprietary and patented microbial technologies to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, proteins, enzymes, certain metabolites and other biologic products at flexible commercial scales, today announced that its management and representatives will participate in the following two upcoming industry events in july 2022:
DYAI Ratings Summary
DYAI Quant Ranking